New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2013
07:15 EDTTHLD, SIThreshold Pharmaceuticals acquires [18F]HX4 from Siemens Healthcare
Threshold Pharmaceuticals (THLD) announced a global agreement with Siemens Healthcare (SI) to acquire its investigational agent [18F]HX4, a radiolabeled hypoxia Positron Emission Tomography, or PET, tracer. [18F]HX4 could potentially be used as a companion diagnostic to hypoxia-targeted therapeutics based on Threshold's drug discovery platform. Threshold initially intends to develop [18F]HX4 to determine a patient's tumor hypoxia profile, which may identify patients who will best respond to Threshold's hypoxia-targeted therapeutics. Under the terms of the agreement, Siemens will transfer ownership and existing preclinical, clinical and manufacturing data related to [18F]HX4 to Threshold.
News For THLD;SI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
07:12 EDTSICongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
07:11 EDTSIAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
October 9, 2014
19:02 EDTTHLDThreshold Pharmaceuticals licenses rights to development program for Hypoxin
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use